RSI Expert-Nataliya Karyakina

Nataliya Karyakina

Senior Toxicologist, Health Risk Analyst

Joined RSI in 2008

  • DABT Certificate in general toxicology (2021-2026)

  • Solid background and knowledge in medicine, epidemiology, and toxicology

  • 30+ experience in hazard identification and risk assessment of chemicals

  • Extensive experience in hazard-based classification of hazardous chemicals

  • Significant experience in the development of health-based safety values

  • Extensive experience in conducting systematic reviews

Dr. Nataliya Karyakina is a Senior Toxicologist and Health Risk Analyst at Risk Sciences International (RSI), where she has served since 2008. She plays a central role in RSI’s work at the intersection of chemical safety, regulatory science, and human health. Drawing on more than three decades of experience, Dr. Karyakina contributes to complex projects involving the evaluation and assessment of hazardous properties of chemicals with different modes of action, hazard-based classification of chemical substances under CLP (EC) 1272/2008, and the development of health-based safety values for industrial and environmental chemicals for both workers and the general population.

At RSI, Dr. Karyakina has led and co-led multidisciplinary projects addressing the health effects of essential and toxic metals (e.g., manganese, aluminum, lithium, barium, lanthanum, titanium, praseodymium), engineered nanomaterials (e.g., nanoalumina, titanium dioxide), endocrine disruptors (e.g., bisphenol A, phytoestrogens), and pharmaceuticals (e.g., statins, ethinyl estradiol, and other human and veterinary drugs). Her work also includes the application of new approach methodologies (NAMs) to hazard identification and risk assessment, identification of early molecular initiating and key events leading to carcinogenicity, and the evaluation of current clinical approaches and criteria for the diagnosis of occupational manganism.

She has been a key contributor to projects for Health Canada, the Canadian Food Inspection Agency (CFIA), the United States Environmental Protection Agency (US EPA), the European Chemicals Agency (ECHA), and to international research collaborations under the REACH and CLP regulations. These efforts have included hazard and human health risk assessment projects involving recommendations for classification under CLP (EC) 1272/2008, and the derivation of Derived No-Effect Levels (DNELs) and occupational exposure guidance values.

Her systematic reviews on human health risk assessments related to exposure to talc, aluminum, manganese neurotoxicity, traditional and non-traditional biomarkers, and nanomaterials have been widely cited and used to inform international decision-making. Most of these publications were conducted in collaboration with the RSI team and international experts in their respective fields. Dr. Karyakina has also co-authored numerous publications on toxicological modeling, biomonitoring, and regulatory science in high-impact journals such as Critical Reviews in Toxicology, Neurotoxicology, Environmental Toxicology and Health, Regulatory Toxicology and Pharmacology, Journal of Toxicology and Environmental Health, and Patty’s Toxicology.

Pre-RSI

Dr. Karyakina began her career in Kyiv, Ukraine, earning a B.Sc. in Medicine and an M.Sc. in Epidemiology from Bogomolets National Medical University in 1983. She completed her Ph.D. in Toxicology in 1992 at the Ukrainian Scientific and Research Institute of Pharmacology and Toxicology, where her dissertation focused on establishing environmental safety standards for novel plant growth regulators—work that foreshadowed her later expertise in environmental exposure assessment and regulatory toxicology.

She went on to serve for more than a decade as a research scientist at the L.I. Medved’s Research Center of Preventive Toxicology, Food and Chemical Safety of the Ministry of Health of Ukraine (formerly the Scientific Research Institute of Hygiene and Toxicology of Pesticides, Polymers, and Plastics, Ministry of Public Health of the USSR). There, she was responsible for:

  • Assessing the toxicity of various chemical compounds in different animal species via inhalation, oral, and dermal exposure routes;
  • Conducting diverse types of toxicity tests, including studies of acute and sub-acute toxicity, evaluation of cumulative properties, chronic toxicity testing, and determination of toxicity thresholds;
  • Assessing and predicting toxicological parameters based on metabolic analogies, persistence, and relationships between chemical structure and physicochemical properties, as well as performing interpolation and extrapolation within homologous series;
  • Studying the environmental behavior of chemicals—their persistence and migration in soil, water, and air—and analyzing the dependence of these indices on pH, temperature, and moisture content; and
  • Preparing rationale documents for the development of health-based standards in various environmental media to ensure the safe use of pesticides.

In 2005, after relocating to Canada, Dr. Karyakina joined the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa. There, she contributed to numerous projects addressing the health risk assessment of endocrine-active chemicals; the potential risks associated with asbestos exposure in Canada; the main risk factors for the transmission of prion diseases in both animals and humans [Bovine Spongiform Encephalopathy (BSE) and variant Creutzfeldt-Jakob Disease (vCJD)]; and the psychosocial ripple effects of chemical, biological, and nuclear terrorist attacks in international contexts. This period cemented her reputation as a dedicated scientist, equally adept at quantitative risk assessment and at framing complex risk issues within their broader societal context.

Nataliya, presenting a poster during a workshop.

Case studies associated with Nataliya Karyakina

Systematic Review of Artificial Sweeteners and Health Risks

PROJECT DESCRIPTION

A comprehensive systematic review was undertaken to assess experimental evidence regarding the potential health risks associated with artificial sweeteners, specifically focusing on cancer and pre-term delivery. The client sought a rigorous analysis of both in vivo and in vitro experimental...
Read More about Systematic Review of Artificial Sweeteners and Health Risks

Publications associated with Nataliya Karyakina

Diagnosis of manganism and manganese neurotoxicity: A workshop report.


ABSTRACT

With declining exposures to manganese (Mn) in occupational settings, there is a need for more sensitive exposure assessments and clinical diagnostic criteria for manganism and Mn neurotoxicity. To address this issue, a workshop was held on November 12-13, 2020, with...
Publication details about Diagnosis of manganism and manganese neurotoxicity: A workshop report.

Review of non-invasive biomarkers as a tool for exposure characterization in human health risk assessments.


ABSTRACT

Blood and urine are historically the most frequent matrices used for measuring chemical levels in human biomonitoring studies. As biomonitoring programs are refreshed, consideration of specific priority substances and specific population targets provide opportunities for inclusion of alternative non- or...
Publication details about Review of non-invasive biomarkers as a tool for exposure characterization in human health risk assessments.

Biomarkers for occupational manganese exposure.


ABSTRACT

Long-term inhalation exposure to manganese (Mn) metal or its inorganic compounds can result in manganism or subclinical neurofunctional deficits. Studies have described affected workers in Mn dioxide mining, Mn-containing ore crushing and milling facilities, manufacturing of dry-cell batteries, Mn steel...
Publication details about Biomarkers for occupational manganese exposure.

Magnetic resonance imaging T1 indices of the brain as biomarkers of inhaled manganese exposure.


ABSTRACT

Excessive exposure to manganese (Mn) is linked to its accumulation in the brain and adverse neurological effects. Paramagnetic properties of Mn allow the use of magnetic resonance imaging (MRI) techniques to identify it in biological tissues. A critical review was...
Publication details about Magnetic resonance imaging T1 indices of the brain as biomarkers of inhaled manganese exposure.

Overview of REACH: Issues Involved in the Registration of Metals.


ABSTRACT

New European legislation known as REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) was introduced in 2007 to increase the speed at which the health and/or environmental risks of industrial chemicals were being assessed and managed (REACH (EC) No 1907/2006)....
Publication details about Overview of REACH: Issues Involved in the Registration of Metals.

The REACH registration process: A case study of metallic aluminium, aluminium oxide and aluminium hydroxide.


ABSTRACT

The European Union's REACH Regulation requires determination of potential health and environmental effects of chemicals in commerce. The present case study examines the application of REACH guidance for health hazard assessments of three high production volume (HPV) aluminium (Al) substances:...
Publication details about The REACH registration process: A case study of metallic aluminium, aluminium oxide and aluminium hydroxide.

Biomarkers of environmental manganese exposure.


ABSTRACT

We conducted a critical review on biomarkers of environmental manganese (Mn) exposure to answer the following questions: 1) are there reliable biomarkers of internal Mn exposure (Mn in biological matrices) associated with external metrics of Mn exposure (Mn in environmental...
Publication details about Biomarkers of environmental manganese exposure.

Derivation of whole blood biomonitoring equivalents for lithium for the interpretation of biomonitoring data.


ABSTRACT

INTRODUCTION: Lithium salts have numerous industrial uses and are also used in the treatment of bipolar disorders. The main source of lithium exposure to the general population is drinking water and foods. Lithium is nephrotoxic at higher doses. Thus, oral...
Publication details about Derivation of whole blood biomonitoring equivalents for lithium for the interpretation of biomonitoring data.

Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data.


ABSTRACT

Biomonitoring equivalents (BEs) have been increasingly applied for biomonitoring purposes by regulatory bodies worldwide. The present report describes the development of a BE for titanium based on a 4-step process: (i) identification of a critical study/point of departure (PoD) supporting...
Publication details about Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data.

Search all publications

Outside RSI

Outside of work, Nataliya is an avid reader who embraces books as a way to experience “more than one life in more than one place,” echoing her favorite quote by Anne Tyler. She also enjoys harvesting wild mushrooms and birdwatching, activities that bring her a deep sense of connection to nature and the universe.

Dr. Karyakina is highly respected by her colleagues for her depth of professional expertise and unwavering dedication to public health protection.

Direct contact with Nataliya Karyakina

Contact Form to Staff

Admin view only

Your name
Your name
First Name
Last Name